These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34747496)

  • 21. Exploring the Neuroinflammatory Pathway in Epilepsy and Cognitive Impairment: Role of HMGB1 and Translational Challenges.
    Ngadimon IW; Seth EA; Shaikh MF
    Front Biosci (Landmark Ed); 2024 Jun; 29(6):229. PubMed ID: 38940048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating miR-146a and miR-134 in predicting drug-resistant epilepsy in patients with focal impaired awareness seizures.
    Leontariti M; Avgeris M; Katsarou MS; Drakoulis N; Siatouni A; Verentzioti A; Alexoudi A; Fytraki A; Patrikelis P; Vassilacopoulou D; Gatzonis S; Sideris DC
    Epilepsia; 2020 May; 61(5):959-970. PubMed ID: 32314378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-analysis of HMGB1 levels in the cerebrospinal fluid and serum of patients with epilepsy.
    Chen Y; Chen X; Liang Y
    Neurol Sci; 2023 Jul; 44(7):2329-2337. PubMed ID: 36933099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time courses of HMGB1 and other inflammatory markers after generalized convulsive seizures.
    Nass RD; Wagner M; Surges R; Holdenrieder S
    Epilepsy Res; 2020 May; 162():106301. PubMed ID: 32126476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective clinical trials to investigate clinical and molecular biomarkers.
    Auvin S; Walker L; Gallentine W; Jozwiak S; Tombini M; Sills GJ
    Epilepsia; 2017 Jul; 58 Suppl 3():20-26. PubMed ID: 28675556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of HMGB1, toll-like receptor and RAGE in human Rasmussen's encephalitis.
    Luan G; Gao Q; Zhai F; Chen Y; Li T
    Epilepsy Res; 2016 Jul; 123():36-49. PubMed ID: 27108105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between high-mobility group box 1 levels and febrile seizures in children: a systematic review and meta-analysis.
    Li S; Zhao Q; Sun J; Yan W; Wang J; Gao X; Li X; Ren C; Hao L
    Sci Rep; 2023 Mar; 13(1):3619. PubMed ID: 36869074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-1 type 1 receptor/Toll-like receptor signalling in epilepsy: the importance of IL-1beta and high-mobility group box 1.
    Maroso M; Balosso S; Ravizza T; Liu J; Bianchi ME; Vezzani A
    J Intern Med; 2011 Oct; 270(4):319-26. PubMed ID: 21793950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Potential Therapeutic Role of the HMGB1-TLR Pathway in Epilepsy.
    Wang S; Guan Y; Li T
    Curr Drug Targets; 2021; 22(2):171-182. PubMed ID: 32729417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GluR3B Antibody Was a Biomarker for Drug-Resistant Epilepsy in Patients With Focal to Bilateral Tonic-Clonic Seizures.
    Lai Q; Li Q; Li X; Wang H; Zhang W; Song X; Hu P; Yao R; Fan H; Xu X
    Front Immunol; 2022; 13():838389. PubMed ID: 35464426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-high mobility group box protein 1 monoclonal antibody downregulating P-glycoprotein as novel epilepsy therapeutics.
    de Liyis BG; Tandy SG; Endira JF; Putri KA; Utami DKI
    Egypt J Neurol Psychiatr Neurosurg; 2022; 58(1):121. PubMed ID: 36310854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HMGB1 mediates microglia activation via the TLR4/NF-κB pathway in coriaria lactone induced epilepsy.
    Shi Y; Zhang L; Teng J; Miao W
    Mol Med Rep; 2018 Apr; 17(4):5125-5131. PubMed ID: 29393419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High Mobility Group Box-1 (HMGB1): A Potential Target in Therapeutics.
    Vijayakumar EC; Bhatt LK; Prabhavalkar KS
    Curr Drug Targets; 2019; 20(14):1474-1485. PubMed ID: 31215389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of Ceruloplasmin in the Peripheral Blood of Patients With Drug-Resistant Epilepsy.
    Chen HY; Pan YX; Li XB; Yun YF; Yang GX; Jiang YM; Lu D; Huang JM
    J Clin Pharmacol; 2023 Apr; 63(4):466-472. PubMed ID: 36433654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of HMGB1 and TLR4 in neuropsychiatric systemic lupus erythematosus patients with seizure disorders.
    Huang Q; Shen S; Qu H; Huang Y; Wu D; Jiang H; Yuan C
    Ann Transl Med; 2020 Jan; 8(1):9. PubMed ID: 32055600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HMGB-1, TLR4, IL-1R1, TNF-α, and IL-1β: novel epilepsy markers?
    Kamaşak T; Dilber B; Yaman SÖ; Durgut BD; Kurt T; Çoban E; Arslan EA; Şahin S; Karahan SC; Cansu A
    Epileptic Disord; 2020 Apr; 22(2):183-193. PubMed ID: 32301731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Animal Models of Seizures and Epilepsy: Past, Present, and Future Role for the Discovery of Antiseizure Drugs.
    Löscher W
    Neurochem Res; 2017 Jul; 42(7):1873-1888. PubMed ID: 28290134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Receptor for Advanced Glycation Endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures.
    Iori V; Maroso M; Rizzi M; Iyer AM; Vertemara R; Carli M; Agresti A; Antonelli A; Bianchi ME; Aronica E; Ravizza T; Vezzani A
    Neurobiol Dis; 2013 Oct; 58():102-14. PubMed ID: 23523633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Redox-Dependent HMGB1 Isoforms as Pivotal Co-Ordinators of Drug-Induced Liver Injury: Mechanistic Biomarkers and Therapeutic Targets.
    Lea JD; Clarke JI; McGuire N; Antoine DJ
    Antioxid Redox Signal; 2016 Apr; 24(12):652-65. PubMed ID: 26481429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance analysis of EEG seizure detection features.
    Niknazar H; Mousavi SR; Niknazar M; Mardanlou V; Coelho BN
    Epilepsy Res; 2020 Nov; 167():106483. PubMed ID: 33049435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.